“…In particular, the PA biosynthetic pathway is very active during cancer cell growth, and PA content is increased in tumor cells and tissues, such as breast, colon, skin, and prostate cancers. , Given the role of natural PAs in cancer, efforts have been made in search for strategies that target the PA metabolism, which might be useful for tumor treatment. , In this context, the main investigated strategies have been pointed to reduce intracellular PA concentration by inhibition of their synthesis or transport across cell membranes as well as through the use of analogues that interfere with PA metabolism. More recently, the strategy of exploiting PA-degrading enzymes to induce cancer cells death has been applied. , Indeed, the oxidative deamination of PAs catalyzed by some amine oxidases causes an over-production of aldehydes and hydrogen peroxide, which are cytotoxic and can damage cancer cells, causing apoptosis/necrosis and ultimately cell death. − The induction of oxidative stress by increasing ROS has recently received great attention in anticancer therapies, and the effect of various anticancer drugs is based on the principle of oxidative stress-induced chemotherapy; for example, 2-methoxyestradiol induces mitochondrial production of hydrogen peroxide and subsequently activates c-Jun N-terminal kinase (JNK), resulting in apoptosis initiation …”